Please use this identifier to cite or link to this item:
|Title:||Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.|
|Authors:||Angus, Peter W;Locarnini, S A;McCaughan, Geoffrey W;Jones, Robert M;McMillan, J S;Bowden, D S|
|Affiliation:||Liver Transplant Unit, Austin Hospital, Heidelberg, Victoria, Australia.|
|Citation:||Hepatology (baltimore, Md.); 21(1): 14-8|
|Abstract:||The factors that predispose patients undergoing liver transplantation for hepatitis B virus (HBV) disease to severe recurrence of infection are unclear. In this study we examined the effect of pretransplantation infection with HBV and precore variant strains of HBV on posttransplantation outcome and allograft histology in 24 patients who survived more than 3 months after liver transplantation. Based on pretransplantation serum HBV DNA status as detected by the polymerase chain reaction (PCR) and direct sequencing, the 24 patients could be assigned to three groups. In group 1 there were 4 patients HBV DNA-negative before transplantation and none of these patients suffered recurrence of infection posttransplantation. In group 2, of 10 patients with pretransplantation infection with wild-type virus, 7 became reinfected, and 1 of these developed HBV-related graft failure. In group 3, 9 of 10 patients infected with precore mutant HBV strains became reinfected. However, in contrast to the patients in group 2, 7 patients in group 3 developed HBV-related graft loss, and 5 of these patients had fibrosing cholestatic hepatitis (FCH). These results indicate that infection with precore mutant strains of HBV predisposes a patient to early graft loss following transplantation.|
|Internal ID Number:||7806147|
Hepatitis B Core Antigens.genetics
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.